Business · 03/06/2015
FDA Requests Stakeholder Participation in Generic Drug User Fee Reauthorization
The FDA is seeking input from public stakeholders, including patient groups and healthcare professionals, on the reauthorization of the Generic Drug User Fee Amendments of 2012, which expires in September 2017.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →